Dose identification of triamcinolone acetonide for noninvasive pre‐corneal administration in the treatment of posterior uveitis using a rapid, sensitive HPLC method with photodiode‐array detector

Volume: 36, Issue: 2
Published: Nov 12, 2021
Abstract
Triamcinolone acetonide (TAA) is the drug of choice in the management of ocular inflammations due to its anti-inflammatory and immuno-suppressant activity. Available marketed formulations (Triesence, Trivaris, Kenalog) are in the suspension form recommended to be administered via intravitreal injection, which has many major complications. In the present study, we have designed and evaluated Hydroxypropyl-β-cyclodextrin (HP-β-CD),) based...
Paper Details
Title
Dose identification of triamcinolone acetonide for noninvasive pre‐corneal administration in the treatment of posterior uveitis using a rapid, sensitive HPLC method with photodiode‐array detector
Published Date
Nov 12, 2021
Volume
36
Issue
2
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.